The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Identification Of Biomarkers For Alzheimers Disease
Funder
National Health and Medical Research Council
Funding Amount
$607,489.00
Summary
Alzheimer's disease is the most common age-related neurodegenerative disease, and the most common cause of dementia. It is estimated that 212,000 Australians suffer from dementia and this will rise to approximately 730,000 by 2050. Currently there are no definitive diagnostic methods for AD. The research described in this application seeks to identify and validate a range of biomarkers identified in the blood of patients that would be suitable to use for diagnostic purposes.
Metabolomic Analysis Of Leishmania Parasites; Identifying Metabolic Pathways Required For Pathogenesis
Funder
National Health and Medical Research Council
Funding Amount
$605,963.00
Summary
Leishmania are single-celled parasites that target a major class of immune cell, affecting millions and killing thousands of people worldwide. We have developed new approaches for investigating how these parasites survive in the immune cells, and why different species of Leishmania cause markedly different pathologies. This information will be used to identify and validate new drug targets in these parasites.
Development Of High-throughput Screening Assays For Detecting Early Gastric Cancer: Translating Proteomics Research Into Clinical Outcomes Using Emerging Mass Spectrometry And Photonics Technologies
Funder
National Health and Medical Research Council
Funding Amount
$655,438.00
Summary
Gastric cancer (GC) is the second leading cause of cancer death worldwide, claiming the lives of >11,000 Australians from 1996-2006. Individuals diagnosed with GC have an expected 5-year survival rate of 10-30%. This could be improved if cases were identified in the early stages of the disease where treatments are more effective. Researchers from Adelaide and Melbourne are developing a diagnostic assay for early-stage GC based on a novel detection system that requires only a drop of blood.
Biochemistry And Functional Significance Of Glycosylation Of Apolipoprotein E
Funder
National Health and Medical Research Council
Funding Amount
$485,000.00
Summary
Apolipoprotein E (apoE) is an important molecule which affects our risk of atherosclerosis- coronary disease and of Alzheimer's disease. We know that apoE's functions are very much affected by its structure. One aspect of tis structure which has been neglected is the attachment of sugar molecules . These are very likely to regulate how apoE interacts with other molecules, with cells, and is metabolised in the body and will be investigated in this project.
Remodelling Of Bacterial Outer Membranes: Implications For Vaccine Development.
Funder
National Health and Medical Research Council
Funding Amount
$558,189.00
Summary
We have identified proteins located in bacteria that are responsible for growth and the transport of essential nutrients. We will use a combination of bacterial genetics, protein biochemistry and immunological techniques to fully characterize these proteins. This strategic knowledge has direct implications for vaccine development and National security, since similar species of bacteria were amongst the first biological weapons.
Discovery And Validation Of Alzheimer�s Disease Biomarkers In Human Plasma
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
With life expectancy increasing Alzheimer�s disease (AD) poses a rising medical and socioeconomic challenge, emphasising the need for the development of prevention and treatment strategies. Such strategies will be most effective if administered early in the disease process, making early diagnosis critical to their success. The identification of biomarkers in this project, which are altered during the development of AD, will lead to the development of such a means to diagnosis AD at an early stag ....With life expectancy increasing Alzheimer�s disease (AD) poses a rising medical and socioeconomic challenge, emphasising the need for the development of prevention and treatment strategies. Such strategies will be most effective if administered early in the disease process, making early diagnosis critical to their success. The identification of biomarkers in this project, which are altered during the development of AD, will lead to the development of such a means to diagnosis AD at an early stage, when interventions will have the most impact.Read moreRead less